Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

Decreased Apoptotic Priming and Loss of Bcl-2 Dependence Are Functional Hallmarks of Richter's Syndrome

Antonella Rigo, Tiziana Vaisitti, Carlo Laudanna, Matilde Micillo, Flavia Merigo, Alessio Montresor, Andrea Sbarbati, Kevin Mellert, Peter Moeller, Fabrizio Vinante, Silvia Deaglio, Isacco Ferrarini

Blood (2022) 140 (Supplement 1): 1809–1810.

https://doi.org/10.1182/blood-2022-160380

Published: 2022

Journal Articles

Molecular Characteristics of Diffuse Large B-Cell Lymphoma and Correlation with Baseline Metabolic Tumor Volume (MTV), Interim Positron Emission Tomography (iPET) and Outcome in the PETAL Trial

Julia Richter, PhD, Andreas Hüttmann, MD, Jan Rekowski, MSc, Christine Schmitz, MD, Selina Gärtner, MS, BS, Claudia Ose, MSc, Andreas Rosenwald, Martin-Leo Hansmann, Sylvia Hartmann, MD, Peter Moeller, MD, Hans-Heinrich Wacker, MD, Alfred Feller, Christoph Thorns, MD, Stefan P. Müller, MD, Ulrich Duehrsen, MD, Wolfram Klapper, MD

Blood (2018) 132 (Supplement 1): 4188.

https://doi.org/10.1182/blood-2018-99-112815

Published: 2018

Journal Articles

Ibrutinib Can Induce Complete Remissions and Sustained Responses in Refractory Cutaneous or Leg-Type Diffuse Large B-Cell Lymphoma

Johannes Bloehdorn, MD, Stephanie Ellen Weissinger, MD, Anca Sindrilaru, MD, Stefan Schoensteiner, MD, Thorsten Peters, MD, Peter Moeller, MD, Ralf Marienfeld, PhD, Andreas Viardot, MD

Blood (2018) 132 (Supplement 1): 4237.

https://doi.org/10.1182/blood-2018-99-117032

Published: 2018

Journal Articles

Primary Extranodal Diffuse Large B-Cell Lymphomas Are Enriched for Mutations in MYD88 and CD79B.

Stephanie Ellen Weissinger, MD, Peter Moeller, MD, Ralf Marienfeld, PhD, Johannes Bloehdorn, MD, Andreas Viardot, MD

Blood (2018) 132 (Supplement 1): 1701.

https://doi.org/10.1182/blood-2018-99-114551

Published: 2018

Journal Articles

A New Stromal Signature Applicable to Formalin-Fixed Paraffin-Embedded Tissues Identifies Patients at Risk in Prospective Clinical Trials of the German High-Grade Non-Hodgkin Lymphoma Study Group

Blood (2018) 132 (Supplement 1): 343.

https://doi.org/10.1182/blood-2018-99-112450

Published: 2018

Journal Articles

The Clinical Impact of the Cell-of-Origin Classification and the MYC+/BCL2+ Double Expresser Status in DLBCL Treated within Prospective Clinical Trials of the Dshnhl

Blood (2016) 128 (22): 151.

https://doi.org/10.1182/blood.V128.22.151.151

Published: 2016

Journal Articles

Nivolumab Induces Remission in High- PD-L1 Expressing Aggressive B-Non Hodgkin Lymphoma: A Single Center Experience

Stephan R Bohl, Stefan Schoensteiner, Henriette Huber, MD, Florian Kuchenbauer, Peter Moeller, MD, Stephanie E Weissinger, MD, Andreas Viardot

Blood (2016) 128 (22): 1865.

https://doi.org/10.1182/blood.V128.22.1865.1865

Published: 2016

Journal Articles

Recurrent Mutations of the Exportin 1 Gene ( XPO1 ) in Primary Mediastinal B-Cell Lymphoma: A Lysa Study

Fabrice Jardin, MD PhD, Anais Pujals, PhD, Laura Pelletier, PhD, Elodie Bohers, PhD, Vincent Camus, Sylvain Mareschal, Sydney Dubois, Marlène Ochman, MD, Francois Lemonnier, MD, Pierre-Julien Viailly, Philippe Bertrand, PhD, Catherine Maingonnat, Alexandra Traverse-Glehen, Philippe Gaulard, MD PhD, Diane Damotte, MD PhD, Richard Delarue, MD, Corinne Haioun, MD PhD, Yosef Landesman, PhD, William Senapedis, PhD, Christian Argueta, PhD, Gilles Andre Salles, MD PhD, Jean-Philippe Jais, MD PhD, Martin Figeac, PhD, Christiane Copie-Bergman, MD PhD, Thierry Molina, Jean-Michel Picquenot, PhD, Marie Cornic, Thierry Fest, MD PhD, Noel Milpied, Emilie Lemasle, MD, Aspasia Stamatoullas, MD, Peter Moeller, MD, Martin JS Dyer, MA, DPhil, FRCP, FRCPath, Christer Sundstrom, MD PhD, Christian Bastard, MD PhD, Hervé Tilly, MD PhD, Karen Leroy, MD PhD

Blood (2015) 126 (23): 129.

https://doi.org/10.1182/blood.V126.23.129.129

Published: 2015

Journal Articles

Identification of Blut, a Novel Long-Noncoding RNA Differentially Expressed in Burkitt Lymphoma

Blood (2015) 126 (23): 3875.

https://doi.org/10.1182/blood.V126.23.3875.3875

Published: 2015

Journal Articles

Downregulation Of FOXO1 Prevents Induction Of The Tumor Suppressor BLIMP-1 In Classical Hodgkin Lymphoma

Marion J. Vogel, Linka Xie, Hanfeng Guan, Clarissa D. Weitzer, Frank Leithäuser, Peter Moeller, Thomas Wirth, Alexey Ushmorov

Blood (2013) 122 (21): 3794.

https://doi.org/10.1182/blood.V122.21.3794.3794

Published: 2013

Journal Articles

Absence Of BRAF and KRAS Hotspot Mutations In Primary Mediastinal and Other Diffuse Large B-Cell Lymphoma

Philipp D Nagel, Fenja M Feld, Stephanie E Weissinger, Albrecht Stenzinger, MD, Peter Moeller, Jochen K Lennerz, MD PhD

Blood (2013) 122 (21): 4325.

https://doi.org/10.1182/blood.V122.21.4325.4325

Published: 2013

Journal Articles

Constitutively Active STAT6 Represses BCL6 in Primary Mediastinal B Cell Lymphoma.

Olga Ritz, Dr. rer. nat., Jochen K Lennerz, MD PhD, Karolin Rommel, MSc, Karola Dorsch, Elena Kelsch, Julia Melzner, Michaela Buck, Karen Leroy, MD, Silke Brüderlein, Dr. hum. biol., Peter Moeller, MD

Blood (2012) 120 (21): 2417.

https://doi.org/10.1182/blood.V120.21.2417.2417

Published: 2012

Journal Articles

Interleukin-21-Induced Granzyme B-Expressing B Lymphocytes Infiltrate Tumors and Regulate T Cells

Stefanie Lindner, Karen Dahlke, Kai Sontheimer, Magdalena Hagn, MD, Christof Kaltenmeier, Thomas F.E. Barth, Thamara Beyer, Frank Reister, MD, Dorit Fabricius, MD, Ramin Lotfi, MD, Oleg Lunov, PhD, Ulrich Nienhaus, PhD, Thomas Simmet, MD, Rolf Kreienberg, MD, Peter Moeller, MD, PhD, Hubert Schrezenmeier, MD, Bernd Jahrsdörfer, MD

Blood (2012) 120 (21): 3278.

https://doi.org/10.1182/blood.V120.21.3278.3278

Published: 2012

Journal Articles

SOCS1 Mutation Subtypes Predict Divergent Outcomes in DLBCL Patients

Jochen K Lennerz, MD, PhD, Birgit Schif, Christian W Kohler, PhD, Stefan Bentink, PhD, Markus Kreuz, Ingo Melzner, PhD, Lorenz Trümper, Markus Löffler, MD, Rainer Spang, Peter Moeller, MD

Blood (2012) 120 (21): 419.

https://doi.org/10.1182/blood.V120.21.419.419

Published: 2012

Journal Articles

Repression of Mir-106b Family Members Does Not Alter Cell Cycle Progression in Hodgkin Lymphoma

Johan H Gibcus, PhD, Lu Ping Tan, BSc, MSc, Rikst Nynke Schakel, BSc, Geert Harms, BSc, Peter Moeller, MD, PhD, Sibrand Poppema, MD, PhD, Bart-Jan Kroesen, PhD, Anke Van Den Berg, PhD

Blood (2008) 112 (11): 4722.

https://doi.org/10.1182/blood.V112.11.4722.4722

Published: 2008

Journal Articles

High Resolution Screening of Genomic Aberrations in Follicular Lymphoma Using Microarray Based Comparative Genomic Hybridization (MATRIX-CGH).

Carsten Schwaenen, MD, Swen Wessendorf, MD, Andreas Viardot, MD, Sandra Ruf, TA, Martina Enz, TA, Holger Kohlhammer, MD, Hans A. Kestler, Thomas F.E. Barth, MD, Peter Moeller, MD, Hartmut Doehner, MD, Peter Lichter, PhD, Martin Bentz, MD

Blood (2004) 104 (11): 2271.

https://doi.org/10.1182/blood.V104.11.2271.2271

Published: 2004

NARROW

Decreased Apoptotic Priming and Loss of Bcl-2 Dependence Are Functional Hallmarks of Richter's Syndrome

Molecular Characteristics of Diffuse Large B-Cell Lymphoma and Correlation with Baseline Metabolic Tumor Volume (MTV), Interim Positron Emission Tomography (iPET) and Outcome in the PETAL Trial

Ibrutinib Can Induce Complete Remissions and Sustained Responses in Refractory Cutaneous or Leg-Type Diffuse Large B-Cell Lymphoma

Primary Extranodal Diffuse Large B-Cell Lymphomas Are Enriched for Mutations in MYD88 and CD79B.

A New Stromal Signature Applicable to Formalin-Fixed Paraffin-Embedded Tissues Identifies Patients at Risk in Prospective Clinical Trials of the German High-Grade Non-Hodgkin Lymphoma Study Group

The Clinical Impact of the Cell-of-Origin Classification and the MYC+/BCL2+ Double Expresser Status in DLBCL Treated within Prospective Clinical Trials of the Dshnhl

Nivolumab Induces Remission in High- PD-L1 Expressing Aggressive B-Non Hodgkin Lymphoma: A Single Center Experience

Recurrent Mutations of the Exportin 1 Gene ( XPO1 ) in Primary Mediastinal B-Cell Lymphoma: A Lysa Study

Identification of Blut, a Novel Long-Noncoding RNA Differentially Expressed in Burkitt Lymphoma

Downregulation Of FOXO1 Prevents Induction Of The Tumor Suppressor BLIMP-1 In Classical Hodgkin Lymphoma

Absence Of BRAF and KRAS Hotspot Mutations In Primary Mediastinal and Other Diffuse Large B-Cell Lymphoma

Constitutively Active STAT6 Represses BCL6 in Primary Mediastinal B Cell Lymphoma.

Interleukin-21-Induced Granzyme B-Expressing B Lymphocytes Infiltrate Tumors and Regulate T Cells

SOCS1 Mutation Subtypes Predict Divergent Outcomes in DLBCL Patients

Repression of Mir-106b Family Members Does Not Alter Cell Cycle Progression in Hodgkin Lymphoma

High Resolution Screening of Genomic Aberrations in Follicular Lymphoma Using Microarray Based Comparative Genomic Hybridization (MATRIX-CGH).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only